Dr Russell Cohen, recently spoke at the IBD Clinical Challenges and Emerging Therapies conference and discussed key takeaways from his session on JAK inhibitors and their role in clinical practice.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
